|
summary: This clinical trial evaluated the impact of interferon beta on the disease course in people with their first clinical episode suggestive of MS. They found it to be useful in delaying progression to disability and preventing some new relapses.
authors: Motamed MR, Najimi N, Fereshtehnejad SM.
source: Clin Neurol Neurosurg. 2007 May;109(4):344-9.
weblink: click here
category: Clinical Trials and Therapeutics
related research news: click here
glossary:
Clinical trial
Disability
Interferon
Multiple sclerosis
Relapse
Sclerosis
|